Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CXCL13-CXCR5 signaling in CD8<sup>+</sup> T cell recruitment and lymphoid immune organization in clear cell renal cell carcinoma.

Cancer immunology, immunotherapy : CII·2026
Same author

CXCL13-CXCR5 Signaling in CD8<sup>+</sup> T Cell Recruitment and Lymphoid Immune Organization in Clear Cell Renal Cell Carcinoma.

bioRxiv : the preprint server for biology·2026
Same author

Obesity and breast density enhance immune exclusion in the primary tumor microenvironment and promote breast cancer metastasis.

Oncogene·2026
Same author

Ultrasonography-Based Measurements of Endometrial Thickness in Patients With p53 Abnormal Endometrial Carcinomas.

Obstetrics and gynecology·2025
Same author

Detection of PIK3CA Mutations in Anal Dysplasia.

The Journal of surgical research·2025
Same author

Fibronectin composition and transglutaminase 2 cross-linking cooperatively regulate ovarian cancer cell adhesion in ECM-mimetic constructs.

Acta biomaterialia·2025

Related Experiment Video

Updated: Jan 15, 2026

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.6K

Ovarian Mucinous Neoplasms: An Integrated Clinicopathologic Perspective.

Madhuchhanda Roy, Stephanie M McGregor

    Archives of Pathology & Laboratory Medicine
    |October 7, 2025
    PubMed
    Summary

    Primary ovarian mucinous neoplasms are heterogeneous and challenging to classify, impacting patient outcomes. Recent grading updates may simplify diagnosis for early-stage disease, while advanced stages require further biomarker research for tailored treatments.

    More Related Videos

    Transplantation Into the Mouse Ovarian Fat Pad
    09:25

    Transplantation Into the Mouse Ovarian Fat Pad

    Published on: September 7, 2016

    11.9K
    Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
    09:08

    Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

    Published on: January 12, 2020

    7.2K

    Related Experiment Videos

    Last Updated: Jan 15, 2026

    Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
    12:42

    Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

    Published on: August 28, 2012

    15.6K
    Transplantation Into the Mouse Ovarian Fat Pad
    09:25

    Transplantation Into the Mouse Ovarian Fat Pad

    Published on: September 7, 2016

    11.9K
    Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
    09:08

    Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

    Published on: January 12, 2020

    7.2K

    Area of Science:

    • Gynecologic Pathology
    • Oncology
    • Tumor Heterogeneity

    Background:

    • Primary ovarian mucinous neoplasms are common but morphologically heterogeneous, posing diagnostic challenges.
    • Current classification relies on morphology, leading to significant interobserver variability.
    • Tumor stage and growth patterns critically influence prognosis and treatment resistance.

    Purpose of the Study:

    • Review current diagnostic criteria for ovarian mucinous tumors.
    • Highlight updates in grading and ancillary testing.
    • Discuss classification challenges in relation to clinical management.

    Main Methods:

    • Review of published peer-reviewed literature.
    • Incorporation of authors' personal experience in gynecologic pathology.

    Main Results:

    • Ovarian mucinous tumor classification remains problematic due to spatial heterogeneity and discordance between gross and histologic findings.
    • Intraoperative assessment presents significant challenges impacting real-time surgical management.
    • Growth pattern-based grading offers a potential simplification for low-stage disease classification.

    Conclusions:

    • Accurate classification of ovarian mucinous neoplasms is crucial for effective clinical management.
    • New grading systems may improve diagnostic consistency for early-stage tumors.
    • Ancillary testing and biomarker research are essential for optimizing therapy in high-stage ovarian mucinous neoplasms.